awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q55053748-82C4E75D-91C0-4BBE-AA8A-590D1BEAA666
Q55053748-82C4E75D-91C0-4BBE-AA8A-590D1BEAA666
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55053748-82C4E75D-91C0-4BBE-AA8A-590D1BEAA666
Sorafenib in the treatment of thyroid cancer.
P2860
Q55053748-82C4E75D-91C0-4BBE-AA8A-590D1BEAA666
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55053748-82C4E75D-91C0-4BBE-AA8A-590D1BEAA666
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f4201798c0fc613be81822fe54759ae460fdb41
P2860
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.